Rubius Therapeutics enters agreement to buy former Alexion site in Smithfield

SMITHFIELD – Rubius Therapeutics Inc., the Cambridge, Mass.-based company recently approved by the R.I. Commerce Corp. for up to $9 million in incentives to occupy and invest in a manufacturing site in Rhode Island, announced it has signed a purchase and sale agreement with Alexion Pharmaceuticals Inc. for a 135,000-square-foot facility in Smithfield at 100…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -